Gene · 2030
Papers2,306
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,306
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Ticagrelor as a dual RAS modulator and mitochondrial stabilizer: A multifaceted neurotherapeutic strategy in Huntington's disease. | Neuropharmacology | 2026 | 41115590 | PubTator, text mining | PubMed |
| Uridine-Based PET/NIRF Dual-Modality imaging for precision tumor diagnosis and surgery. | Eur J Nucl Med Mol Imaging | 2026 | 40991020 | PubTator, text mining | PubMed |
| Hydroxychavicol in Combination with 5-Fluorouracil Induced Apoptosis by Inhibiting Purine Metabolism in HT-29 and DLD-1 Cell Lines. | Chin J Integr Med | 2026 | 40358878 | PubTator, text mining | PubMed |
| Unveiling the Hidden Risk: Ticagrelor-Induced Bradyarrhythmias and Conduction Complications in ACS Patients-Case Series. | J Cardiovasc Dev Dis | 2025 | 41590834 | PubTator, text mining | PubMed |
| Adenosine receptors on the immuno-oncology expressway: TIME, perspectives, and translation. | Front Immunol | 2025 | 41583489 | PubTator, text mining | PubMed |
| Targeted degradation of Pin1 by an antagonistic peptide enhances gemcitabine therapy in pancreatic cancer. | RSC Med Chem | 2025 | 41574233 | PubTator, text mining | PubMed |
| Molecular guided therapy leading to exceptional response in relapsed osteosarcoma. | Front Pharmacol | 2025 | 41560724 | PubTator, text mining | PubMed |
| Cordycepin in cancer therapy: A bibliometric analysis and review of mechanisms. | J Food Drug Anal | 2025 | 41525190 | PubTator, text mining | PubMed |
| Inhibition of equilibrative nucleoside transporters 1 and 2 by proteolysis-targeting chimeras (PROTACs). | J Pharmacol Exp Ther | 2025 | 41478667 | PubTator, text mining | PubMed |
Characterization of genetically modified human embryonic kidney 293 cells lacking equilibrative nucleoside transporter subtype 2, or both subtypes 1 and 2, and the impact of their loss on sensitivity to chemotherapeutic purine/pyrimidine analogs. | Drug Metab Dispos | 2025 | 41349356 | PubTator, text mining | PubMed |
| Solute Carrier Gene Polymorphism (SLC29A1) in Relation to Treatment Outcome and Hematological Changes in Chronic Hepatitis C Patients Treated With Direct Acting Antivirals Plus Ribavirin. | J Med Virol | 2025 | 41235914 | PubTator, text mining | PubMed |
| Genetic factors for hematological traits in pigs. | Anim Genet | 2025 | 40968682 | PubTator, text mining | PubMed |
| CUB domain-containing protein 1 signaling dysregulates gemcitabine metabolism contributing to therapeutic resistance in T24 cells. | PLoS One | 2025 | 40892739 | PubTator, text mining | PubMed |
| Virgin Coconut Oil and Its Lauric Acid, Between Anticancer Activity and Modulation of Chemotherapy Toxicity: A Review. | J Xenobiot | 2025 | 40863333 | PubTator, text mining | PubMed |
| Integrating Machine Learning and Multiomics Analyses to Identify Immune-Related Biomarkers and Mechanisms in Primary Biliary Cholangitis. | Clin Transl Gastroenterol | 2025 | 40844515 | PubTator, text mining | PubMed |
| Dynamic shifts in trophoblast nucleos(t)ide metabolism, transport, and adenosine signaling during gestation and preterm birth. | Sci Rep | 2025 | 40825832 | PubTator, text mining | PubMed |
| GLUT3 enhances chemosensitivity in glioblastoma by transporting temozolomide and capecitabine. | Cell Death Discov | 2025 | 40813374 | PubTator, text mining | PubMed |
| Replication program of a single-chromosome budding yeast strain. | Nucleic Acids Res | 2025 | 40808303 | PubTator, text mining | PubMed |
| A polymeric nanovesicle delivers sulfopin and gemcitabine to remodel tumor microenvironment for enhanced chemoimmunotherapy against orthotopic pancreatic cancer. | Mater Today Bio | 2025 | 40799994 | PubTator, text mining | PubMed |
| Experimental and computational approaches for evaluating molecule interactions with equilibrative nucleoside transporters 1 and 2. | J Pharmacol Exp Ther | 2025 | 40779912 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2030/papers?page=3